Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded potential discoveries into new therapeutic approaches. Current efforts centers on targeting the underlying pathophysiology of MSA. One approach under investigation involves pharmacological interventions to modulate the activity of